ZERO Prostate Cancer Webinar_banner

Health Disparities in Prostate Cancer for Black Men

Prostate cancer survivor Robert Ginyard at a 2020 event

Urologist Dr. Kelvin Moses and prostate cancer survivor Robert Ginyard delve into the historical disparities surrounding prostate cancer. They explore actionable steps to bridge these gaps, highlighting the potential of immunotherapy as a game-changer in this pursuit.


decorative background image


Dr. Kelvin Moses
Kelvin Moses, MD, PhD, Member, Board of Directors

Dr. Kelvin A. Moses is an Associate Professor of Urologic Surgery at Vanderbilt University Medical Center, and director of the Comprehensive Prostate Cancer Clinic.

He is a Phi Beta Kappa graduate of Morehouse College, and received his MD and PhD training at Baylor College of Medicine. He completed his urology training at Emory University, followed by a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow.

His clinical practice focuses on advanced prostate cancer, including conducting several clinical trials, as well as surgical management of advanced renal and testicular cancer. His work focuses on addressing health disparities in urologic cancers, determining the role of health literacy in patient interactions with the health care system, and optimal care for patients with metastatic and/or castrate-resistant prostate cancer. Dr. Moses also serves on ZERO's Board of Directors and Medical Advisory Board.